ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 783

$1.1M Total Retail Price of All Prescriptions

Rank: 38 out of 783

541 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 9,652 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 745 453 S3 1 2
FUROSEMIDE 398 252 2 7
OMEPRAZOLE 380 263 3 6
BYSTOLIC 372 253 4 99
AMLODIPINE BESYLATE 358 284 5 5
PREDNISONE 320 225 6 36
SPIRIVA 295 181 7 59
POTASSIUM CHLORIDE 293 203 8 16
LEVOTHYROXINE SODIUM 270 175 9 1
ADVAIR DISKUS 266 193 10 50
LOSARTAN POTASSIUM 249 204 11 18
KLOR-CON M20 248 176 12 48
CYMBALTA 243 176 13 35
WARFARIN SODIUM 214 181 14 10
SYMBICORT 212 155 15 157
ZOLPIDEM TARTRATE 211 119 16 23
SINGULAIR 191 139 17 90
LEVOFLOXACIN 179 127 18 75
SYNTHROID 171 129 19 47
ATORVASTATIN CALCIUM 153 124 20 11
SIMVASTATIN 152 124 21 3
CRESTOR 145 109 22 27
HYDROCHLOROTHIAZIDE 143 118 23 12
BUMETANIDE 143 102 23 131
CLOPIDOGREL 133 99 25 29
RANEXA 118 92 26 276
AZITHROMYCIN 107 83 27 41
GABAPENTIN 103 39 28 15
PROAIR HFA 101 56 29 56
ISOSORBIDE MONONITRATE ER 99 72 30 40
METOPROLOL TARTRATE 99 79 30 9
METOPROLOL SUCCINATE 99 78 30 13
AZOR 99 70 30 287
NEXIUM 98 74 34 28
METOCLOPRAMIDE HCL 97 73 35 121
ESCITALOPRAM OXALATE 97 79 35 54
MONTELUKAST SODIUM 96 56 37 160
DIOVAN 93 72 38 49
SERTRALINE HCL 93 62 38 22
METFORMIN HCL 89 52 40 8
PLAVIX 88 69 41 51
DOXYCYCLINE HYCLATE 87 63 42 112
BENICAR 85 73 43 182
PANTOPRAZOLE SODIUM 85 57 43 30
JANUMET 82 51 45 217
CARVEDILOL 80 54 46 21
MELOXICAM 79 51 47 37
METOLAZONE 76 53 48 186
DIGOXIN 76 76 48 61
POLYETHYLENE GLYCOL 3350 73 51 50 43
DEXILANT 72 41 51 225
LOSARTAN-HYDROCHLOROTHIAZIDE 72 69 51 53
ALLOPURINOL 71 47 53 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 53 53 95
LISINOPRIL 70 52 55 4
RANITIDINE HCL 69 38 56 44
AMIODARONE HCL 64 43 57 175
PEN NEEDLE 63 44 58 103
METFORMIN HCL ER 63 40 58 64
PRAVASTATIN SODIUM 63 54 58 14
FLUCONAZOLE 61 20 61 179
LYRICA 61 24 61 98
TAMSULOSIN HCL 61 50 61 26
NAMENDA 61 60 61 32
TEKTURNA 60 59 65 317
SPIRONOLACTONE 59 43 66 57
LEVEMIR FLEXPEN 57 22 67 155
CELEBREX 57 49 67 93
THEOPHYLLINE ANHYDROUS 56 33 69 219
CLONIDINE HCL 55 44 70 60
IBUPROFEN 55 38 70 115
LANTUS SOLOSTAR 54 34 72 91
ALPRAZOLAM 53 35 73 145
TRAMADOL HCL 52 39 74 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.